K.S. Meshkova (1), V.V. Gudkova (2), L.V. Stakhovskaya (2)
DEPENDENCE OF DEVELOPMENT OF STROKE ON ARTERIAL HYPERTENSION AND THE ISSUES OF CHOICE OF ANTIHYPERTENSIVE THERAPY
|
8-13 |
E.I. Chukanova, A.S. Chukanova
DISTINCT MECHANISMS OF PATHOGENESIS OF CEREBROVASCULAR INSUFFICIENCY
|
14-19 |
S.V. Prokopenko, E.G. Shanina, M.M. Petrova, E.Yu. Mozheyko
NEURORESTORATION: MODERN VIEWS ON THE PROBLEM
|
20-24 |
O.A. Lvova, V.V. Gusev
THE PLACE OF ANTIPLATELET AGENTS IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE IN CHILDREN AND YOUNG PATIENTS
|
26-30 |
M.G. Glezer
NEW ORAL ANTICOAGULANTS IN THE PREVENTION OF VENOUS THROMBOSIS AND THROMBOEMBOLISM: FOCUS ON RIVAROXABAN
|
31-39 |
A.I. Kaminny, Yu.A. Shuvalova, T.A. Shishova, V.I.Kaminnaya, V.S. Tutunov, D.I. Soboleva, V.V. Kukharchuk
THE EFFICACY AND SAFETY OF THERAPY WITH ROSUVASTATIN. THE RESULTS OF 8-WEEK "5 TO 40" STUDY
|
40-46 |
N.A. Konyshko, A.V.Krikova
EVALUATION OF RATIONAL USE OF ANTIHYPERTENSIVE DRUGS IN PREGNANT WOMEN WITH SOMATIC PATHOLOGY
|
47-50 |
F.A. Khabirov (1, 2), T.I. Khaybullin (1, 2), L.A. Averyanova (2), N.N.Babicheva (2), E.V.Granatova (2)
EVALUATION OF EFFECTIVENESS OF THIOCTIC ACID IN THE CORRECTION OF SENSORY DISORDERS IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
|
51-56 |
N.N. Zavadenko
ATTENTION DEFICIT HYPERACTIVITY DISORDER: CURRENT APPROACHES TO THE DIAGNOSIS AND DRUG TREATMENT
|
57-62 |
A.R. Tatarsky, D.A. Kirillova
CORONARY ARTERY DISEASE. CHRONIC OBSTRUCTIVE PULMONARY DISEASE. HEART FAILURE AND RESPIRATORY FAILURE: DIFFERENTIAL DIAGNOSIS, TREATMENT
|
63-71 |
A.B. Danilov (1), P.R. Kamchatnov (2), A.V. Chugunov (2)
POTENTIALS FOR THE INCREASING THE EFFICACY AND SAFETY OF TREATMENT OF PATIENTS WITH LOW BACK PAIN
|
72-75 |
E.I. Astashkin, M.G. Glezer
ROLE OF DIFFERENT TYPES OF RENIN-ANGIOTENSIN SYSTEM IN PATHOGENESIS OF CARDIOVASCULAR DISEASES. FOCUS ON VALSARTAN
|
76-83 |
P.R. Kamchatnov (1), A.B. Danilov (2), M.A. Evzelman (3)
COMBINATION THERAPY OF PATIENTS WITH LOW-BACK PAIN
|
84-89 |
T.V. Potupchik (1), O.F. Veselova (1), L.S. Evert (2)
PHARMACODYNAMIC ASPECTS OF USE OF SOME NOOTROPICS IN COGNITIVE DISORDERS
|
90-95 |